previously scientific reports of CagriSema uncovered that it assisted individuals achieve drastically larger weight loss than semaglutide (Wegovy) did. even though Lilly's Zepbound/Mounjaro topples Wegovy, It is achievable that CagriSema could enter the industry at the appropriate time for Novo Nordisk to retain its In general Management inside the